LexaGene Holdings Future Growth
Future criteria checks 2/6
LexaGene Holdings is forecast to grow revenue at 50.8% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 18.3% |
Revenue growth rate | 50.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 18 Jan 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
2/28/2026 | 28 | N/A | 2 | 2 | 1 |
2/28/2025 | 15 | N/A | -4 | -4 | 1 |
2/29/2024 | 7 | N/A | -7 | -7 | 1 |
2/28/2023 | 3 | N/A | -8 | -8 | 1 |
11/30/2022 | 0 | -9 | -7 | -7 | N/A |
8/31/2022 | 0 | -10 | -8 | -8 | N/A |
5/31/2022 | 0 | -10 | -9 | -9 | N/A |
2/28/2022 | 0 | -11 | -10 | -10 | N/A |
11/30/2021 | 0 | -11 | -10 | -10 | N/A |
8/31/2021 | 0 | -11 | -11 | -11 | N/A |
5/31/2021 | 0 | -11 | -10 | -10 | N/A |
2/28/2021 | 0 | -10 | -9 | -9 | N/A |
11/30/2020 | N/A | -9 | -8 | -8 | N/A |
8/31/2020 | N/A | -9 | -7 | -7 | N/A |
5/31/2020 | N/A | -8 | -6 | -6 | N/A |
2/29/2020 | N/A | -7 | -5 | -5 | N/A |
11/30/2019 | N/A | -8 | -6 | -6 | N/A |
8/31/2019 | N/A | -8 | -5 | -5 | N/A |
5/31/2019 | N/A | -8 | -6 | -6 | N/A |
2/28/2019 | N/A | -8 | -6 | -6 | N/A |
11/30/2018 | N/A | -7 | -6 | -6 | N/A |
8/31/2018 | N/A | -7 | -6 | -5 | N/A |
5/31/2018 | N/A | -5 | -5 | -5 | N/A |
2/28/2018 | N/A | -4 | -4 | -4 | N/A |
11/30/2017 | N/A | -3 | -3 | -3 | N/A |
8/31/2017 | N/A | -6 | -2 | -2 | N/A |
5/31/2017 | N/A | -5 | -2 | -2 | N/A |
2/28/2017 | N/A | -4 | -1 | -1 | N/A |
11/30/2016 | N/A | -4 | -1 | -1 | N/A |
8/31/2016 | N/A | 0 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 5XS2's forecast earnings growth is above the savings rate (0.2%).
Earnings vs Market: Insufficient data to determine if 5XS2's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if 5XS2's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 5XS2's revenue (50.8% per year) is forecast to grow faster than the German market (4.6% per year).
High Growth Revenue: 5XS2's revenue (50.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 5XS2's Return on Equity is forecast to be high in 3 years time